Invitrogen™ Galiximab Recombinant Human Monoclonal Antibody (IDEC-114 (Galiximab))

Human Recombinant Monoclonal Antibody

Supplier:  Invitrogen™ MA548059

Catalog No. PIMA548059

Description

Specificity: Galiximab is a primatized mAb which consists of human constant and primate (cynomolgus macaque) variable regions and binds specifically to CD80.

Galiximab is a chimeric monoclonal antibody which is used as an immunosuppressive pharmaceutical.

Specifications

• Antigen: Galiximab
• Classification: Recombinant Monoclonal
• Concentration: 1 mg/mL
• Formulation: PBS with 0.02% ProClin 300
• Gene Accession No.: P06213
• Host Species: Human
• Purification Method: Protein A
• Regulatory Status: RUO
• Gene ID (Entrez): 3643
• Content And Storage: Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
• Form: Liquid

• Applications: ELISA, Flow Cytometry, Inhibition Assays, Immunohistochemistry, Immunoprecipitation, Western Blot
• Clone: IDEC-114 (Galiximab)
• Conjugate: Unconjugated
• Gene: INSR
• Gene Alias: IDEC-114
• Immunogen: Galiximab was prepared by immunizing cynomolgus monkeys with recombinant CD80 antigen.
• Quantity: 200 μg
• Primary or Secondary: Primary
• Target Species: Human
• Product Type: Antibody
• Isotype: IgG1 λ